Overview
Metabolism is the sum of the chemical reactions that extract energy from food and then store or distribute it. Hormonal signals such as insulin, glucagon, GLP-1 (glucagon like peptide 1), GIP (glucose dependent insulinotropic polypeptide) and amylin coordinate this regulation. The gut and the pancreas release these peptides after nutrient intake, and so do other tissues.
Research focus
Metabolic pathway research studies receptor pharmacology, energy balance and incretin signaling: how single, dual and triple agonists bind the GLP-1, GIP and glucagon receptors, and what each signal does in cell and animal models.
Catalogue products
Tirzepatide (dual GIP/GLP-1), Retatrutide (triple GIP/GLP-1/glucagon), and MOTS-C are the catalogue compounds associated with metabolic and receptor pharmacology research.
For research and development use only. Not for human or veterinary use or consumption.
Retatrutide is a triple agonist of the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1) and glucagon receptors, used as a reference compound in incretin and glucagon receptor pharmacology research models.
MOTS-c is a mitochondrial-genome-encoded peptide studied in rodent models for regulation of insulin sensitivity, AMPK signaling, and metabolic/age-related homeostasis.
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist used as a reference compound in incretin pathway research models.
References
Research publications describe the materials and methods used in those studies. They do not verify the contents of an individual Radian vial.